Latest Administration News

Immuron Limited reports topline results from a Uniformed Services University trial of a third-party ETEC product that missed its primary endpoint, reaffirming commitment to its established Travelan dosing ahead of FDA discussions.

Lotus Resources plans a significant share consolidation to better align its capital structure with its ASX300 status, aiming to attract a broader investor base. The move, subject to shareholder approval, coincides with a proposed update to the company’s constitution.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

FireFly Metals has launched a dual capital raising initiative, combining a $5 million Share Purchase Plan for eligible shareholders and a C$15 million Canadian flow-through share offer, aimed at funding key development and exploration activities at its Green Bay Copper-Gold Project.

ChemX Materials Limited has successfully completed its voluntary administration process with creditors approving restructuring agreements for both the parent company and its subsidiary HiPurA Pty Ltd. This marks a significant step towards stabilising operations and returning control to the board.

ChemX Materials Limited has emerged from voluntary administration following a Deed of Company Arrangement, while securing a significant Japanese patent for its HiPurA® High Purity Alumina process.

EPX Limited has submitted a proposal to acquire WattWatchers Pty Limited through a Deed of Company Arrangement, pending creditor approval. The move aims to integrate WattWatchers’ real-time energy monitoring solutions with EPX’s advanced building performance platform.

Lifestyle Communities is extending an option for existing homeowners to adopt a revised Deferred Management Fee model following a pivotal VCAT ruling, aiming to enhance transparency and goodwill regardless of the appeal outcome.

Felix Gold Limited has successfully raised $18 million through a placement to fund exploration and advance near-term military-grade antimony production in Alaska. The capital injection positions the company to capitalize on strategic supply opportunities amid global market shifts.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

DMC Mining's progress in Guinea is stalled as the government halts new exploration licences until after the December presidential election, prompting a 12-month extension on acquisition terms.

Imugene has secured FDA backing to advance its allogeneic CAR T therapy, azer-cel, into a pivotal Phase 3 trial targeting difficult-to-treat diffuse large B-cell lymphoma (DLBCL), including patients relapsed after prior CAR-T treatment.